Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of cancer using GFR alpha-4 chimeric antigen receptor

Treatment of cancer using GFR alpha-4 chimeric antigen receptor

US Patent 11970525 · Granted Apr 30, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for retrieving tumor-related antibodies and antigens2025
Antibody compounds with reactive arginine and related antibody drug conjugates2025
Humanized anti-GDNF family alpha-receptor 4 (GRF-alpha-4) antibodies and chimeri2025
Humanized anti-GDNF family alpha-receptor 4 (GRF-alpha-4) antibodies and chimeri2025
Humanized anti-GDNF family alpha-receptor 4 (GRF-alpha-4) antibodies and chimeri2025
Methods for improving the efficacy and expansion of immune cells2025
Treatment of cancer using humanized anti-BCMA chimeric antigen receptor2025
Method of redirecting t cells to treat HIV infection2024
Canine monoclonal antibodies against canine cytotoxic T lymphocyte associated pr2024
Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy2024
Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy2024
Compositions and methods of muscle specific kinase chimeric autoantibody recepto2024